Stay updated with breaking news from Nasdaq Qlgn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Qualigen Therapeutics, Inc. (NASDAQ:QLGN – Get Free Report) was the target of a large decline in short interest in the month of October. As of October 15th, there was short interest totalling 37,900 shares, a decline of 14.4% from the September 30th total of 44,300 shares. Based on an average trading volume of 19,900 shares, […]
Qualigen Therapeutics, Inc. (NASDAQ:QLGN – Get Free Report)’s stock price was down 3.9% during mid-day trading on Monday . The stock traded as low as $0.97 and last traded at $0.98. Approximately 4,231 shares were traded during mid-day trading, a decline of 97% from the average daily volume of 150,806 shares. The stock had previously […]
In Vivo Efficacy Study Demonstrates QN-247 as Potential Therapeutic Approach in Rare Breast Cancer Type CARLSBAD, Calif., April 18, 2023 (GLOBE...
CARLSBAD, Calif., March 21, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life sciences...
CARLSBAD, Calif., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life sciences...